ERK couples chronic survival of NK cells to constitutively activated Ras in lymphoproliferative disease of granular lymphocytes (LDGL)
- 1 November 2004
- journal article
- Published by Springer Science and Business Media LLC in Oncogene
- Vol. 23 (57), 9220-9229
- https://doi.org/10.1038/sj.onc.1208122
Abstract
Chronic NK lymphoproliferative disease of large granular lymphocytes (LDGL) is characterized by the expansion of activated CD3-, CD16+ or CD56+ lymphocytes. The mechanism of survival of NK cells from LDGL patients is unknown but may be related to antigenic stimulation. There is currently no standard effective therapy for LDGL, and the disease is characteristically resistant to standard forms of chemotherapy. We found evidence of constitutive activation of extracellular-regulated kinase (ERK) in NK cells from 13/13 patients with NK-LDGL (one patient with aggressive and 12 patients with chronic disease). Ablation of ERK activity by inhibitors or a dominant-negative form of MEK, the upstream activator of ERK, reduced the survival of patient NK cells. Ras was also constitutively active in patient NK cells, and exposure of cells to the Ras inhibitor FTI2153 or to dominant-negative-Ras resulted not only in ERK inhibition but also in enhanced apoptosis in both the presence and absence of anti-Fas. Therefore, we conclude that a constitutively active Ras/MEK/ERK pathway contributes to the accumulation of NK cells in patients with NK-LDGL. These findings suggest that strategies to inhibit this signaling pathway may be useful for the treatment of the NK type of LDGL.This publication has 36 references indexed in Scilit:
- Dysregulated NK receptor expression in patients with lymphoproliferative disease of granular lymphocytesBlood, 2004
- Complex expression of natural killer receptor genes in single natural killer cellsImmunology, 2002
- The “ex Vivo” Patterns of CD2/CD7, CD57/CD11c, CD38/CD11b, CD45RA/CD45RO, and CD11a/HLA-DR Expression Identify Acute/Early and Chronic/Late NK-Cell Activation StatesBlood Cells, Molecules, and Diseases, 2002
- MAPK/ERK Overrides the Apoptotic Signaling from Fas, TNF, and TRAIL ReceptorsOnline Journal of Public Health Informatics, 2001
- PD 098059 Is a Specific Inhibitor of the Activation of Mitogen-activated Protein Kinase Kinase in Vitro and in VivoOnline Journal of Public Health Informatics, 1995
- Guanine-nucleotide-releasing factor hSos1 binds to Grb2 and links receptor tyrosine kinases to Ras signallingNature, 1993
- Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosisNature, 1992
- Chromosomal abnormalities define clonal proliferation in CD3‐ large granular lymphocyte leukemiaAmerican Journal of Hematology, 1990
- Human natural killer cells isolated from peripheral blood do not rearrange T cell antigen receptor beta chain genes.The Journal of Experimental Medicine, 1986
- Analysis of T-Cell Receptor Gene Rearrangement and Expression in Human Natural Killer ClonesScience, 1985